The mitogen-activated protein (MAP) kinase phosphatase (MKP) family plays an important function in regulating the pro-inflammatory cytokines by deactivating MAP kinases. MKP-1 is essential for the dephosphorylation of p38 MAP kinase that regulates expression of IL-6, TNF-α, and IL-1β. We hypothesized that MKP-1 regulates inflammatory bone loss in experimental periodontitis. Wild-type and Mkp-1−/− mice received A. actinomycetemcomitans LPS injection in the palatal region or PBS control 3 times/wk for 30 days. Mice were killed, and maxillae were assessed by microcomputed tomography, histological analysis, and TRAP staining for measurement of bone loss, extent of inflammation, and degree of osteoclastogenesis. Results indicated that, in LPS-injected Mkp-1−/− mice, significantly greater bone loss occurred with more inflammatory infiltrate and a significant increase in osteoclastogenesis compared with Mkp-1−/− control sites or either wild-type group. Analysis of these data indicates that MKP-1 plays a key role in the regulation of inflammatory bone loss.
Get full access to this article
View all access options for this article.
References
1.
An H, Yu Y, Zhang M, Xu H, Qi R, Yan X, et al. (2002). Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology106:38–45.
2.
Assuma R, Oates T, Cochran D, Amar S, Graves DT (1998). IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol160:403–409.
3.
Chen P, Li J, Barnes J, Kokkonen GC, Lee JC, Liu Y (2002). Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol169:6408–6416.
4.
Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM, et al. (2006). Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA103:2274–2279.
5.
Delima AJ, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S, et al. (2001). Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol28:233–240.
6.
Delima AJ, Karatzas S, Amar S, Graves DT (2002). Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists. J Infect Dis186:511–516.
7.
Graves DT (1999). The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis28:482–490.
8.
Graves DT, Cochran D (2003). The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol74:391–401.
9.
Hammer M, Mages J, Dietrich H, Servatius A, Howells N, Cato AC, et al. (2006). Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med203:15–20.
10.
Jiang Y, Mehta CK, Hsu TY, Alsulaimani FF (2002). Bacteria induce osteo-clastogenesis via an osteoblast-independent pathway. Infect Immun70:3143–3148.
11.
Keyse SM (2000). Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol12:186–192.
12.
Kikuchi T, Yoshikai Y, Miyoshi J, Katsuki M, Musikacharoen T, Mitani A, et al. (2003). Cot/Tpl2 is essential for RANKL induction by lipid A in osteoblasts. J Dent Res82:546–550.
13.
Kirkwood KL, Li F, Rogers JE, Otremba J, Coatney DD, Kreider JM, et al. (2007). A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss. J Pharmacol Exp Ther320:56–63.
14.
Lau LF, Nathans D (1985). Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J4:3145–3151.
15.
Liew FY, Xu D, Brint EK, O’Neill LA (2005). Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol5: 446–458.
16.
Liu Y, Shepherd EG, Nelin LD (2007). MAPK phosphatases—regulating the immune response. Nat Rev Immunol7:202–212.
17.
Mori Y, Yoshimura A, Ukai T, Lien E, Espevik T, Hara Y (2003). Immunohistochemical localization of Toll-like receptors 2 and 4 in gingival tissue from patients with periodontitis. Oral Microbiol Immunol18:54–58.
18.
Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, et al. (2000). Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun275:768–775.
19.
Nimah M, Zhao B, Denenberg AG, Bueno O, Molkentin J, Wong HR, et al. (2005). Contribution of MKP-1 regulation of p38 to endotoxin tolerance. Shock23:80–87.
20.
Rogers JE, Li F, Coatney DD, Rossa C, Bronson P, Krieder JM, et al. (2007a). Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis. J Periodontol78:550–558.
21.
Rogers JE, Li F, Coatney DD, Otremba J, Kriegl JM, Protter TA, et al. (2007b). A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model. J Periodontol78:1992–1998.
22.
Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T (2006). Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol176:1899–1907.
23.
Schumann RR, Pfeil D, Lamping N, Kirschning C, Scherzinger G, Schlag P, et al. (1996). Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. Blood87:2805–2814.
24.
Shepherd EG, Zhao Q, Welty SE, Hansen TN, Smith CV, Liu Y (2004). The function of mitogen-activated protein kinase phosphatase-1 in peptidogly-can-stimulated macrophages. J Biol Chem279:54023–54031.
25.
Wang X, Nelin LD, Kuhlman JR, Meng X, Welty SE, Liu Y (2008). The role of MAP kinase phosphatase-1 in the protective mechanism of dexam-ethasone against endotoxemia. Life Sci83:671–680.
26.
Wu JJ, Bennett AM (2005). Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling. J Biol Chem280:16461–16466.
27.
Zhao Q, Shepherd EG, Manson ME, Nelin LD, Sorokin A, Liu Y (2005). The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J Biol Chem280:8101–8108.
28.
Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, et al. (2006). MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med203:131–140.
